SG Americas Securities’s Aratana Therapeutics, Inc. PETX Stock Holding History

SG Americas Securities’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-392,251	Closed	-$2.02M	–	3396
2019 Q2	$2.02M	Buy	392,251 +362,708	+1,228%	+$1.63M	0.01%	1005
2019 Q1	$106K	Buy	+29,543	New	+$128K	﹤0.01%	3036
2018 Q2	–	Sell	-13,146	Closed	-$58K	–	3659
2018 Q1	$58K	Buy	+13,146	New	+$58.7K	﹤0.01%	3058
2017 Q2	–	Sell	-14,708	Closed	-$78K	–	3680
2017 Q1	$78K	Sell	14,708 -987	-6%	-$6.67K	﹤0.01%	3048
2016 Q4	$113K	Buy	+15,695	New	+$127K	﹤0.01%	2787
2016 Q2	–	Sell	-10,774	Closed	-$59K	–	3174
2016 Q1	$59K	Buy	+10,774	New	+$40.5K	﹤0.01%	2745
2015 Q2	–	Sell	-8,800	Closed	-$141K	–	2948
2015 Q1	$141K	Buy	+8,800	New	+$157K	﹤0.01%	2082
2014 Q2	–	Sell	-9,232	Closed	-$171K	–	2794
2014 Q1	$171K	Buy	+9,232	New	+$185K	﹤0.01%	1999

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

SG Americas Securities's PETX Position: Q3 2019 in Review

SG Americas Securities sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 392,251 shares — an estimated $2.02M sold.

SG Americas Securities first reported a position in PETX in Q1 2014 and held it in 8 quarters. The position peaked at $2.02M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

SG Americas Securities reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
SG Americas Securities sold 392,251 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $2.02M.
SG Americas Securities first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
SG Americas Securities's Aratana Therapeutics, Inc. position peaked at $2.02M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.